Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 162433
                    [Title] => ‘Smart tablet’ effective in cancers
                    [Summary] => Data presented at the recent 38th annual meeting of the American Society for Clinical Oncology (ASCO) showed that Xeloda (capecitabine), Roche’s new oral tumor-activated chemotherapy treatment, is highly effective at treating gastrointestinal cancers – colorectal, stomach and oesophageal. 


Various study results presented at the ASCO meeting showed that the oral Xeloda has the potential to effectively replace the current standard treatment, intravenous (iv) 5-FU, in gastrointestinal cancers.


                    [DatePublished] => 2002-05-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

Xeloda

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 162433
                    [Title] => ‘Smart tablet’ effective in cancers
                    [Summary] => Data presented at the recent 38th annual meeting of the American Society for Clinical Oncology (ASCO) showed that Xeloda (capecitabine), Roche’s new oral tumor-activated chemotherapy treatment, is highly effective at treating gastrointestinal cancers – colorectal, stomach and oesophageal. 


Various study results presented at the ASCO meeting showed that the oral Xeloda has the potential to effectively replace the current standard treatment, intravenous (iv) 5-FU, in gastrointestinal cancers.


                    [DatePublished] => 2002-05-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

‘Smart tablet’ effective in cancers

May 27, 2002 - 12:00am

Data presented at the recent 38th annual meeting of the American Society for Clinical Oncology (ASCO) showed that Xeloda (capecitabine), Roche’s new oral tumor-activated chemotherapy treatment, is highly effective...

Science and Environment